ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,625, issued on April 21, was assigned to Y-BIOLOGICS INC. (Daejeon, South Korea) and IntoCell Inc. (Daejeon, South Korea). "Antibody bindi... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,627, issued on April 21, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.). "Alpha4Beta7 integrin binding proteins and methods of... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,628, issued on April 21. "Antibodies targeting integrin beta-2" was invented by Sachdev Singh Sidhu (Toronto). According to the abstract*... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,629, issued on April 21, was assigned to Surrozen Operating Inc. (South San Francisco, Calif.). "Monospecific anti-frizzled antibodies and... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,630, issued on April 21, was assigned to MONTEFIORE MEDICAL CENTER (Bronx, N.Y.). "CD25 chimeric antigen receptors and uses thereof" was i... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,631, issued on April 21, was assigned to REMD Biotherapeutics Inc (Camarillo, Calif.). "Antibodies which bind human endothelin receptor a ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,632, issued on April 21, was assigned to Apexigen Inc. (Boston). "Anti-CD40 antibodies and methods of use" was invented by Yongke Zhang (P... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,633, issued on April 21, was assigned to SHANGHAI HENLIUS BIOTECH INC. (Shanghai), SHANGHAI HENLIUS BIOPHARMACEUTICAL Co. LTD. (Shanghai) a... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,634, issued on April 21, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo). "Antibody-pyrrolobenzodiazepine derivative conjugate which b... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,635, issued on April 21, was assigned to Nanjing Legend Biotech Co. Ltd. (Nanjing, China). "Glypican-2-binding moieties, chimeric antigen ... Read More